PDL Biopharma
PDLI
#8394
Rank
NZ$0.51 B
Marketcap
NZ$4.52
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -NZ$0.21 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are NZ$80.61 Million. In 2019 the company made an earning of -NZ$0.12 Billion a decrease over its 2018 earnings that were of -NZ$80.01 Million.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-NZ$0.21 Billion81.73%
2019-NZ$0.12 Billion42.43%
2018-NZ$80.01 Million-121.38%
2017NZ$0.37 B60.41%
2016NZ$0.23 B-77.09%
2015NZ$1.01 B3.09%
2014NZ$0.98 B26.65%
2013NZ$0.78 B19.82%
2012NZ$0.65 B3.68%
2011NZ$0.62 B77.17%
2010NZ$0.35 B-35.29%
2009NZ$0.54 B23.45%
2008NZ$0.44 B-1751.42%
2007-NZ$26.87 Million-88.56%
2006-NZ$0.24 Billion93.73%
2005-NZ$0.13 Billion13.63%
2004-NZ$0.11 Billion32.12%
2003-NZ$80.73 Million87.44%
2002-NZ$43.07 Million-302.45%
2001NZ$21.27 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$63.55 B-26,529.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.20 B-8,501.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.21 Billion-16.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ$63.76 M-126.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 16.39%๐Ÿ‡บ๐Ÿ‡ธ USA